Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $25.2100 (-3.19%) ($25.2100 - $25.2100) on Thu. May. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.65% (three month average) | RSI | 22 | Latest Price | $25.2100(-3.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -9.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(45%) XBI(42%) ARKG(40%) IWO(39%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.825% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.825% (StdDev 3.65%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $13.84(-45.1%) | Resistance Level | $29.78 | 5 Day Moving Average | $26.58(-5.15%) | 10 Day Moving Average | $28.27(-10.82%) | 20 Day Moving Average | $29.78(-15.35%) | To recent high | -46.9% | To recent low | 0% | Market Cap | $3.692b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |